Pfizer targets at least two billion Covid-19 vaccine doses this year
Pfizer Inc said on Tuesday it expects to generate US$15 billion (RM60.66 billion), or about a quarter of its total revenue this year, from sales of its Covid-19 vaccine co-developed with German partner BioNTech SE.
WHILE PFIZER ESTIMATED TO MAKE RM60.66 FROM 2 BILLION VACCINE, TWO COMPANIES IN MALAYSIA WILL MAKE MORE THAN RM60 BILLION FOR JUST 20 MILLION DOSES OF VACCINE FROM TODAY TILL 2023. CONTRACTS HAVE BEEN SIGNED AND SEALED.
IS THIS THE REASON WHY MALAYSIA IS BREAKING ITS OWN RECORD FOR COVID 19?